Real-world study of PD-1/L1 immune checkpoint inhibitors for advanced non-small cell lung cancer after resistance to EGFR-TKIs.

Wei, Kunchen; Zhou, Chao; Chen, Yang; Feng, Xiao; Tang, Hao

Wei, Kunchen; Zhou, Chao; Chen, Yang; Feng, Xiao; Tang, Hao.

Afiliación

Wei K; Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai, China.
Zhou C; Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai, China.
Chen Y; Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai, China.
Feng X; Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai, China.
Tang H; Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Navy Medical University, Shanghai, China.

Front Oncol ; 13: 1217872, 2023.

Article en En | MEDLINE | ID: mdl-37534246

Palabras clave

EGFR TKI resistance; epidermal growth factor receptor; immune checkpoint inhibitor; nomogram; non-small cell lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google